产品编号 | CFN91723 | |
CAS编号 | 73-32-5 | |
分子式 = 分子量 | C6H13NO2 = 131.18 | |
产品纯度 | >=98% | |
物理属性 | Powder | |
化合物类型 | Alkaloids | |
植物来源 | ||
ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 |
产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
L-异亮氨酸 | CFN91723 | 73-32-5 | 10mg | QQ客服:3257982914 |
L-异亮氨酸 | CFN91723 | 73-32-5 | 20mg | QQ客服:3257982914 |
L-异亮氨酸 | CFN91723 | 73-32-5 | 50mg | QQ客服:3257982914 |
L-异亮氨酸 | CFN91723 | 73-32-5 | 100mg | QQ客服:3257982914 |
Description: | L-Isoleucine often impacts muscle repair function, cirrhosis, obesity, cardiovascular disease, glucose and lipid metabolism, blood glucose levels and other conditions. L-Isoleucine administration can regulate the inflammatory response to protect against pathogens in vivo and in vitro, making it for research in dextran sulfate sodium (DSS) (HY-116282) -induced colitis. IC50 & Target: Human Endogenous Metabolite |
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 7.6231 mL | 38.1156 mL | 76.2311 mL | 152.4623 mL | 190.5778 mL |
5 mM | 1.5246 mL | 7.6231 mL | 15.2462 mL | 30.4925 mL | 38.1156 mL |
10 mM | 0.7623 mL | 3.8116 mL | 7.6231 mL | 15.2462 mL | 19.0578 mL |
50 mM | 0.1525 mL | 0.7623 mL | 1.5246 mL | 3.0492 mL | 3.8116 mL |
100 mM | 0.0762 mL | 0.3812 mL | 0.7623 mL | 1.5246 mL | 1.9058 mL |
产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
Calystegine C2; Calystegine C2 | CFN00160 | 190957-44-9 | C7H13NO5 = 191.18 | 5mg | QQ客服:1457312923 |
新瓶草千里光碱; Neosarracine | CFN00314 | 136173-26-7 | C18H27NO5 = 337.41 | 5mg | QQ客服:1413575084 |
对映-9-羟基-15-氧代-16-贝壳杉烯-19-酸 beta-D-吡喃葡萄糖酯; ent-9-Hydroxy-15-oxo-16-kauren-19-oic acid beta-D-glucopyranosyl ester | CFN97291 | 81263-96-9 | C26H38O9 = 494.6 | 5mg | QQ客服:3257982914 |
3,6,19,23-四羟基-12-熊果-28-酸; 3,6,19,23-Tetrahydroxy-12-ursen-28-oic acid | CFN97476 | 91095-51-1 | C30H48O6 = 504.7 | 5mg | QQ客服:1457312923 |